DK152366C - Analogifremgangsmaade til fremstilling af 2,3-alkylen-bis-(oxy)-benzamider eller derivater deraf, samt 2,3-alkylen-bis(oxy)benzoesyre til anvendelse som mellemprodukt ved fremstilling af benzamiderne - Google Patents

Analogifremgangsmaade til fremstilling af 2,3-alkylen-bis-(oxy)-benzamider eller derivater deraf, samt 2,3-alkylen-bis(oxy)benzoesyre til anvendelse som mellemprodukt ved fremstilling af benzamiderne

Info

Publication number
DK152366C
DK152366C DK346977A DK346977A DK152366C DK 152366 C DK152366 C DK 152366C DK 346977 A DK346977 A DK 346977A DK 346977 A DK346977 A DK 346977A DK 152366 C DK152366 C DK 152366C
Authority
DK
Denmark
Prior art keywords
oxy
alkylene
bis
benzamides
analogue
Prior art date
Application number
DK346977A
Other languages
Danish (da)
English (en)
Other versions
DK346977A (da
DK152366B (da
Inventor
Michel Thominet
Gerard Bulteau
Jacques Acher
Claude Collignon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of DK346977A publication Critical patent/DK346977A/da
Publication of DK152366B publication Critical patent/DK152366B/da
Application granted granted Critical
Publication of DK152366C publication Critical patent/DK152366C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK346977A 1976-08-04 1977-08-03 Analogifremgangsmaade til fremstilling af 2,3-alkylen-bis-(oxy)-benzamider eller derivater deraf, samt 2,3-alkylen-bis(oxy)benzoesyre til anvendelse som mellemprodukt ved fremstilling af benzamiderne DK152366C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation
FR7623835 1976-08-04

Publications (3)

Publication Number Publication Date
DK346977A DK346977A (da) 1978-02-05
DK152366B DK152366B (da) 1988-02-22
DK152366C true DK152366C (da) 1988-07-25

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
DK346977A DK152366C (da) 1976-08-04 1977-08-03 Analogifremgangsmaade til fremstilling af 2,3-alkylen-bis-(oxy)-benzamider eller derivater deraf, samt 2,3-alkylen-bis(oxy)benzoesyre til anvendelse som mellemprodukt ved fremstilling af benzamiderne

Country Status (37)

Country Link
JP (1) JPS57167914A (sv)
AR (1) AR219709A1 (sv)
AT (1) AT358034B (sv)
AU (1) AU516033B2 (sv)
BE (1) BE857350A (sv)
BG (1) BG36496A3 (sv)
CA (1) CA1114371A (sv)
CH (1) CH629198A5 (sv)
CS (1) CS216246B2 (sv)
DD (1) DD133237A5 (sv)
DE (1) DE2760414C2 (sv)
DK (1) DK152366C (sv)
EG (1) EG12716A (sv)
ES (1) ES461175A1 (sv)
FI (1) FI63938C (sv)
GR (1) GR61351B (sv)
HK (2) HK40482A (sv)
HU (1) HU179064B (sv)
IE (2) IE45646B1 (sv)
IL (2) IL52644A0 (sv)
IN (1) IN145473B (sv)
LU (1) LU77897A1 (sv)
MC (1) MC1154A1 (sv)
MW (1) MW2077A1 (sv)
NL (1) NL172063C (sv)
NO (1) NO152133C (sv)
NZ (1) NZ184816A (sv)
OA (1) OA05728A (sv)
PH (3) PH22114A (sv)
PL (1) PL111071B1 (sv)
PT (1) PT66865B (sv)
RO (1) RO72963A (sv)
SE (2) SE440776B (sv)
SU (1) SU716523A3 (sv)
YU (1) YU40005B (sv)
ZA (1) ZA774701B (sv)
ZM (1) ZM6077A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Also Published As

Publication number Publication date
DD133237A5 (de) 1978-12-20
IL52644A0 (en) 1977-10-31
HU179064B (en) 1982-08-28
NL7708616A (nl) 1978-02-07
SU716523A3 (ru) 1980-02-15
FI772362A (sv) 1978-02-05
AR219709A1 (es) 1980-09-15
MW2077A1 (en) 1978-12-13
PL111071B1 (en) 1980-08-30
PH17710A (en) 1984-11-19
SE8206546D0 (sv) 1982-11-17
PH22114A (en) 1988-06-01
IE45646B1 (en) 1982-10-20
GR61351B (en) 1978-10-26
SE7708849L (sv) 1978-02-05
NL172063B (nl) 1983-02-01
HK40482A (en) 1982-09-24
IE45646L (en) 1978-02-04
ZA774701B (en) 1979-01-31
IE45647B1 (en) 1982-10-20
OA05728A (fr) 1981-05-31
PH18629A (en) 1985-08-23
FI63938B (fi) 1983-05-31
MC1154A1 (fr) 1978-04-17
NO772739L (no) 1978-02-07
CA1114371A (en) 1981-12-15
DK346977A (da) 1978-02-05
BG36496A3 (en) 1984-11-15
JPS6259090B2 (sv) 1987-12-09
EG12716A (en) 1979-09-30
BE857350A (fr) 1978-02-01
PL200066A1 (pl) 1978-09-11
IN145473B (sv) 1978-10-21
NO152133B (no) 1985-04-29
YU188277A (en) 1983-01-21
SE8206546L (sv) 1982-11-17
HK40382A (en) 1982-09-24
PT66865B (fr) 1978-12-29
ZM6077A1 (en) 1979-05-21
FI63938C (fi) 1983-09-12
ES461175A1 (es) 1978-12-01
AU516033B2 (en) 1981-05-14
DK152366B (da) 1988-02-22
DE2760414C2 (sv) 1990-05-17
RO72963A (ro) 1981-11-24
NZ184816A (en) 1980-11-14
IL66138A0 (en) 1982-09-30
AU2750777A (en) 1979-02-08
SE440776B (sv) 1985-08-19
SE453390B (sv) 1988-02-01
PT66865A (fr) 1977-08-01
NL172063C (nl) 1983-07-01
NO152133C (no) 1985-08-07
IE802409L (en) 1978-02-04
ATA569677A (de) 1980-01-15
CS216246B2 (en) 1982-10-29
YU40005B (en) 1985-06-30
LU77897A1 (sv) 1978-02-09
JPS57167914A (en) 1982-10-16
CH629198A5 (fr) 1982-04-15
SE437027B (sv) 1985-02-04
AT358034B (de) 1980-08-11

Similar Documents

Publication Publication Date Title
DK153399C (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf og 4-aminoquinazolin-forbindelser til anvendelse som udgangsmateriale ved fremgangsmaaden
DK149057C (da) Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-piperazincarboxamider eller -carbothioamider eller syreadditionssalte deraf
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK164545C (da) Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK153493C (da) Analogifremgangsmaade til fremstilling af androstadien-17-carboxylsyreestere samt androstadien-17-carboxylsyrer til anvendelse som mellemprodukt ved fremgangsmaaden
DK148745C (da) Ribofuranosylderivater til anvendelse som mellemprodukter ved fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte deraf
DK149630C (da) Analogifremgangsmaade til fremstilling af tripeptidamider eller -estere eller fysiologisk acceptable syreadditionssalte deraf
DK107077A (da) 4,5-dichlorimidazol-2-carboxylsyrederivater, fremgangsmade til deres fremstilling samt deres anvendelse som skadedyrsbekempelsesmidler
DK341281A (da) Fremgangsmaade til fremstilling af 3,3-dialkyldenzodiazepinderivater eller syreadditionssalte deraf samt ved fremgangsmaaden som mellemprodukter anvendelige forbindelrser
DK281777A (da) Fremgangsmade til fremstilling af 4-hydroxyphenylethylamin-forbindelser eller syreadditionssalte deraf og mellemprodukter til anvendelse ved fremgangsmaden
NO151972C (no) Fremgangsmaate ved fremstilling av silisium eller ferrosilisium ved reduksjon av silisiumdioksyd.
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK159079A (da) Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
DK226476A (da) Fremgangsmade til fremstilling af propargyl-2-phenylamino-imidazoliner-(2) eller syreadditionssalte heraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK157020C (da) Analogifremgangsmaade til fremstilling phenylaminothiopheneddikesyreforbindelser samt funktionelle phenylaminothiopheneddikesyrederivater til anvendelse som udgangsmaterialer ved denne fremgangsmaade
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK144793C (da) Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK152366C (da) Analogifremgangsmaade til fremstilling af 2,3-alkylen-bis-(oxy)-benzamider eller derivater deraf, samt 2,3-alkylen-bis(oxy)benzoesyre til anvendelse som mellemprodukt ved fremstilling af benzamiderne
DK149854C (da) Analogifremgangsmaade til fremstilling af 1,2,4-oxadiazolin-5-oner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf samt mellemprodukter til anvendelse ved fremstillingen
DK584678A (da) Fremgangsmaade til fremstilling af salicylsyre eller derivater deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed